The food and drug agency of Indonesia has approved the single-dose COVID-19 vaccine of US pharmaceutical company Johnson and Johnson (NYSE:JNJ) for emergency use, Reuters news agency reported on Tuesday.
This vaccine is produced by Janssen Pharmaceutical Companies, a part of Johnson & Johnson.
The agency has also approved emergency use of Chinese vaccine company CanSino Biological Inc's (HKG:6185) COVID-19 vaccine.
myTomorrows names new director
GSK's Arexvy receives positive CHMP opinion for at-risk adults aged 50-59
Latigo Biotherapeutics names new chief executive officer
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
Bavarian Nordic's chikungunya vaccine receives validation from EMA for accelerated review
GSK secures global rights to CureVac's mRNA vaccines in new licensing deal
INOVIO names new chief commercial officer
Dynavax Technologies commences dosing in Z-1018 phase 1/2 clinical trial
Bavarian Nordic files for chikungunya vaccine approval in Europe
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada
Philippine lawmakers call for probe into secret US propaganda operation
Gavi seeking funding to immunise poorest children
Sanofi partners with Biovac to manufacture polio vaccines in Africa